No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
AVR Anteris Technologies Global
- 5.140
- -1.640-24.19%
Trading Dec 13 15:46 ET
184.73MMarket Cap-2.60P/E (TTM)
6.000High5.140Low1.96MVolume6.000Open6.780Pre Close11.38MTurnover13.25%Turnover RatioLossP/E (Static)35.94MShares6.00052wk High58.41P/B76.07MFloat Cap5.14052wk Low--Dividend TTM14.80MShs Float6.000Historical High--Div YieldTTM12.68%Amplitude5.140Historical Low5.801Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Australian Medtech Anteris Stock Slides 8% After $89M IPO
Trading Halt: Halt Status Updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation
Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering
Preview: Anteris Technologies Global Corp. Set To IPO Tomorrow
The Australian medical devices company Anteris (AVR.US) has set its IPO pricing at $6.78 per share, aiming to raise $0.1 billion.
The company plans to issue 14.8 million shares at a price of $6.78 per share to raise $0.1 billion in funds.
Anteris Technologies' Subsidiary Launches IPO Roadshow in US
Heat List
US
Overall
Symbol
Price
% Chg
No Data